Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The product has contraindications
We do not purchase from third-party resellers, ensuring the 99% purity standard is met before it reaches your lab
(6) The research team hypothesized that AOD 9604 possibly enhanced the doxorubicin binding to multiple breast cancer cell protein targets, thereby exhibiting greater anti-proliferative activity against the MCF-7 breast cancer cell line compared to chitosan loaded with doxorubicin alone
Specifically air injection during bacteriostatic water addition
Degraded tirzepatide generally becomes less effective rather than harmful
It has also been shown to upregulate the expression of the early growth response gene-1 (Egr-1), a transcription factor that orchestrates the expression of multiple growth factors involved in wo Research Evidence Promotes VEGFR2-mediated angiogenesis in preclinical wound models (McGuire et al., 2025)Stimulates fibroblast migration and tendon outgrowth in ex vivo explant studies (Sikiric et al., 2021)Upregulates Egr-1 transcription factor, driving growth factor expression cascadeDemonstrates stability under physiological conditions due to high proline contentModulates nitric oxide signaling pathways in gastrointestinal and vascular tissue models Bottom line: BPC-157 is one of the most extensively studied synthetic peptides in preclinical regenerative research
US$ 27.79
US$ 27.80
US$ 23.99
US$ 21.96
US$ 22.38
US$ 27.33
US$ 22.50
